Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodies

Abstract INTRODUCTION Current evidence supports the use of cholinesterase inhibitors (ChEIs) as the first‐line symptomatic treatment for improving cognition in dementia with Lewy bodies (DLB). Little is known about current prescribing patterns of ChEIs in DLB. This study aimed to identify the patter...

Descripció completa

Dades bibliogràfiques

Autors principals:	Rachel J. Heo, Ahmed Negida, Kathryn A. Wyman‐Chick, James R. Bateman, Federico Rodriguez‐Porcel, Brian D. Berman, Nitai Mukhopadhyay, Matthew J. Barrett
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-07-01
Col·lecció:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Matèries:	cholinesterase inhibitors dementia with Lewy bodies memantine health‐care delivery physicians’ practice patterns
Accés en línia:	https://doi.org/10.1002/trc2.70136
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!